RMD Open | Publishes peer-reviewed original research on the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases.

Intro Widget

RMD Open publishes high quality peer-reviewed original research covering the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases, including osteoporosis, spine and rehabilitation. Clinical and epidemiological research, basic and translational medicine, interesting clinical cases, and smaller studies that add to the literature are all considered.

It is an online only open access journal that aims to provide rapid publication of research through a continuous publication model. All submitted content is subject to peer review prior to publication. Published work is free to read.

RMD Open is an official journal of EULAR. You can keep up with the latest news via Twitter and Facebook.

Scopus CiteScore: 3.86 (2018)

Editor-in-Chief: Professor Bernard Combe, CHU Lapeyronie, France
Editorial team

Authors

RMD Open considers submissions of a variety of article types, including original articles, short reports and clinical cases.

Information is also provided on editorial policies and open access.

This is an open access journal that levies an Article Publishing Charge (APC). Discounts and waivers are available; details are provided in the Author Information section.

All manuscripts should be submitted online.

Published articles are discoverable via PubMed, Scopus and Google Scholar.

Author information

Submit a paper

Intro Widget

Authors

Latest Articles

Rheumatoid arthritis:

Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis

Epidemiology:

Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendations

Psoriatic arthritis:

Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligible

Rheumatoid arthritis:

Occupational exposure to asbestos and silica and risk of developing rheumatoid arthritis: findings from a Swedish population-based case-control study

Rheumatoid arthritis:

Six-month prospective trial in early and long-standing rheumatoid arthritis: evaluating disease activity in the wrist through sequential synovial histopathological analysis, RAMRIS magnetic resonance score and EULAR-OMERACT ultrasound score

Most Read Articles

Psoriatic arthritis:

Distinguishing rheumatoid arthritis from psoriatic arthritis

Rheumatoid arthritis:

Low rates of radiographic progression of structural joint damage over 2 years of baricitinib treatment in patients with rheumatoid arthritis

Connective tissue diseases:

Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults

Treatments:

Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn’s disease: a pooled analysis of 11 317 patients across clinical trials

Animal models:

Bromodomain protein inhibition: a novel therapeutic strategy in rheumatic diseases

Altmetrics

Related Journals